Company
Investment-firm
Financing round
General
About Company
Industry
Sector :
Subsector :
Contacts
Similar Companies999
Brandon Capital Partners
Brandon Capital Partners is an Australian fund management business specializing in life science investments.
Sector
Subsector
Location
count Of Investments
count Of Exists
SB Life Science
SB Life Science is a venture capital and private equity firm focused on funding and building successful healthcare businesses.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
EMBL Ventures
EMBL Ventures is a German venture capital firm that finances and develops healthcare products and technologies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Apple Tree Partners
Apple Tree Partners is a life sciences venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Financials
Investments15
Modifi Bio
Modifi Biosciences develops novel cancer therapeutics by directly modifying tumor DNA irreparably.
Sector
Subsector
Keywords
Location
total rounds
total raised
Aziyo Biologics
Aziyo develops customized tissue products to restore health and mobility to patients.
Sector
Subsector
Keywords
Location
total rounds
total raised
Modifi Bio
Modifi Biosciences develops novel cancer therapeutics by directly modifying tumor DNA irreparably.
Sector
Subsector
Keywords
Location
total rounds
total raised
Co-Investors
Exits2
Cheetah Medical
Cheetah Medical develops non-invasive cardiac output and hemodynamic monitoring devices.
Sector
Subsector
Keywords
Location
total rounds
total raised
Alphina Therapeutics
Alphina Therapeutics is a biotech company focused on precision medicine for cancer patients.
Sector
Subsector
Keywords
Location
total rounds
total raised
People
Founders3
Kevin Rakin
Mr. Rakin was most recently the President of Regenerative Medicine at Shire plc. Prior to joining Shire, Mr. Rakin served as the Chairman and CEO of Advanced BioHealing from 2007 until its acquisition by Shire, in June 2011. Before this, he served as an executive-in-residence at Canaan Partners. Previously, he was a co-Founder, President & Chief Executive Officer of Genaissance Pharmaceuticals, Inc., a publicly held pharmacogenomics company, until its merger with Clinical Data, Inc. in October 2005. He currently serves as a Board member of CyVek, Inc, Cheetah Medical Inc., Histogenics Corp. and TELA Bio, Inc., and on the executive committee for CURE, Connecticut’s bioscience cluster. He has previously served as a Board member for Ipsogen SA, Vion Pharmaceuticals, Inc., OMRIX Biopharmaceuticals, Inc., and Clinical Data, Inc. Mr. Rakin received an M.B.A. from Columbia University and B.Com and B.Com (Hons) degrees from the University of Cape Town, South Africa.
current job
Kevin Rakin
